Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 30Neoplasms, Plasma Cell 7Breast Neoplasms 5Prostatic Neoplasms 3Pain 3Spinal Cord Compression 2Hematologic Neoplasms 2Bone Neoplasms 2Bone Diseases 2Renal Insufficiency 1Paraproteinemias 1Osteonecrosis 1Osteolysis 1Neoplastic Processes 1Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Hematologic Diseases 1Fractures, Bone 1Disease Progression 1Bone Marrow Diseases 1Blood Protein Disorders 1

Interventions

Lenalidomide 4Dexamethasone 4Bortezomib 3pomalidomide 2Cyclophosphamide 2ricolinostat 1Zoledronic Acid 1Vitamin D 1Transplantation, Autologous 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Calcium Dobesilate 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Zoledronic Acid × Plasma cell × Clear all
NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Novartis

Phase 3 Terminated
143 enrolled 10 charts
Plasma cell

Multiple Myeloma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡